Content about Onco360

October 15, 2013

Cancer-focused specialty pharmacy Onco360 has signed a contract with privately owned pharmacy benefit manager MedImpact Healthcare Systems, whereby the pharmacy will offer its services to the PBM's members.

NEW YORK — Cancer-focused specialty pharmacy Onco360 has signed a contract with privately owned pharmacy benefit manager MedImpact Healthcare Systems, whereby the pharmacy will offer its services to the PBM's members.

The two companies said the partnership would offer MedImpact clients "a unique and effective solution for bending the cost curve," and was aimed at providing benefit payers with a proven and effective cancer pharmacy program that combines a cost-effective dispensing model with "clinical excellence."

August 22, 2013

Inc. magazine released its annual Inc. 5000 list of top companies and for the second straight year, Onco360 has been named one of the fastest growing companies in America, the company stated.

NEW YORK — Inc. magazine released its annual Inc. 5000 list of top companies and for the second straight year, Onco360 has been named one of the fastest growing companies in America, the company stated. When evaluated by revenue, Onco360 is the No. 1 New York State healthcare company on the list.

June 27, 2013

Onco360 is joining the limited-distribution network for two newly approved cancer drugs made by GlaxoSmithKline, the specialty pharmacy company said.

NEW YORK — Onco360 is joining the limited-distribution network for two newly approved cancer drugs made by GlaxoSmithKline, the specialty pharmacy company said.

The New York-based company said it had been selected as a distributor of Tafinlar (dabrafenib) and Mekinist (trametinib). The drugs were approved as standalone therapies, not a combined therapy.

May 20, 2013

The National Association of Specialty Pharmacy has appointed the leader of a cancer-focused specialty pharmacy to its board of directors.

TAMPA, Fla. — The National Association of Specialty Pharmacy has appointed the leader of a cancer-focused specialty pharmacy to its board of directors.

The NASP announced Monday the appointment of Onco360 CEO Burt Zweigenhaft. Onco360 does business as OncoMed, The Oncology Pharmacy, and Zweigenhaft has served as CEO since 2007. The organization said that he had helped Onco360 grow from being a single pharmacy serving oncologists in the New York area to one of the fastest-growing pharmacies of its kind in the country.